Re: Two big thank you’s

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Two big thank you’s

in response to

Re: Two big thank you’s

RVXoldtimer

posted on Nov 24, 2022 07:41PM

RVXOT - ZHCLF has the same CUSIP number as the shares I received in the spin out so there is no differentiation. As for valuation, we'll cross that bridge when/if we get there.